Mechanisms of CNOT3 Tumor Suppression in T-ALL and Identification of New Drugs That Specifically Kill CNOT3-Deficient T-ALL Cells |
Dana-Farber Cancer Institute / Zhaodong Li, PhD |
Young Investigator Grants |
2014 |
Massachusetts |
Using Neurofibromatosis-1 (NF1) to understand Pediatric Brain Tumor Initiation |
MD Anderson Cancer Center / Yuan Pan, PhD |
Young Investigator Grants |
2020 |
Texas |
Anti-Angiogenic Effects of BAI Proteins in Neuroblastoma
|
Children’s Hospital of Philadelphia / Naomi Balamuth, MD |
Young Investigator Grants |
2006 |
Pennsylvania |
Targeting Valine-Specific Amino Acid Dependency -in T-Cell Acute Lymphoblastic Leukemia |
New York University School of Medicine / Palaniraja Thandapani, PhD |
Young Investigator Grants |
2019 |
New York |
Targeting Metabolism as a Therapeutic Approach for High-Risk MYCN-Driven Neuroblastoma |
University of Pennsylvania / Nicole Anderson, PhD |
Young Investigator Grants |
2016 |
Pennsylvania |
MicroRNAs 100 and 125b in Ewing sarcoma |
University of Colorado Denver / Paul Jedlicka |
Young Investigator Grants |
2010 |
Colorado |
Mechanisms of Oncogenic Transformation by TLX1/HOX11 |
University of Michigan / Mark Chiang |
Young Investigator Grants |
2011 |
Michigan |
High-Throughput Gene-Editing via Microfluidic Cell Deformability to Enable Off-the-Shelf Allogeneic Cellular Immunotherapies |
University of California, Los Angeles / Steven Jonas, MD/PhD |
Young Investigator Grants |
2017 |
California |
Development of Immunostimulatory DNA as a Novel Therapy in Pediatric Acute Lymphoblastic Leukemia
|
Children’s Hospital of Philadelphia / Alix Seif, MD, MPH |
Young Investigator Grants |
2008 |
Pennsylvania |
A Translational Approach to Identify Drugs with Specific Activity Against EZH2 Mutant High Risk T-ALLs and ETP ALLs that Overexpress the JDP2 bZIP Transcription Factor |
Dana-Farber Cancer Institute / Shuning He, PhD |
Young Investigator Grants |
2015 |
Massachusetts |